Back to search

United States· US:24979-028_b08ee384-f82b-4f17-9e38-52ebc9187589

Diltiazem Hydrochloride

A diltiazem product containing diltiazem hydrochloride, registered in United States by Upsher-Smith Laboratories, LLC. The same ATC class is registered in 15 of our 19 countries.

ATC C08DB01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDiltiazem HydrochlorideATCC08DB01REGISTER NO.US:24979-028_b08ee384…PACKS LISTED8CHECKEDSeptember 27, 2026

Where it is registered

Diltiazem is registered in 15 of 19 countries.

Countries holding a registration under ATC C08DB01 (diltiazem), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose

Diltiazem · ATC C08DB01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of diltiazem costs, country by country.

Normalised to the WHO defined daily dose (0.24 g), the median price runs from $0.43 in Italy to $0.94 in Switzerland — a ×2.2 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Diltiazem · price per daily dose (0.24 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.94
  • IT Italy$0.43
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DILTIAZEM HYDROCHLORIDE
Manufacturer
Upsher-Smith Laboratories, LLC
Country
United States (US)
ATC code
C08DB01
ATC class
Diltiazem
Defined daily dose
0.24 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 8

  • ndc11
    2497902800
    24000 CAPSULE, EXTENDED RELEASE in 1 PACKAGE (24979-028-00)
  • ndc11
    2497902802
    500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (24979-028-02)
  • ndc11
    2497902806
    30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (24979-028-06)
  • ndc11
    2497902807
    90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (24979-028-07)
  • ndc11
    24979-028-00
  • ndc11
    24979-028-02
  • ndc11
    24979-028-06
  • ndc11
    24979-028-07

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

516 interactions on record for diltiazem.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Diltiazem · interactions on record

516 records

  • 50 severe
  • 259 moderate
  • 29 minor
  • 158 info

Most severe, free to view

  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NaloxegolA06AH03severe
  • LoperamideA07DA03severe

20 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Diltiazem in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diltiazem products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Diltiazem Ratiopharm, Diltiazem Retard G.L
  • Belgium · Diltiazem Retard Eg, Progor
  • Bulgaria · Алдизем, Дилтиазем Софарма
  • Cyprus · Denazox, Diazem
  • Czechia · Diacordin Retard
  • Germany · Diltiazem Abz, Diltiazem Ethypharm
  • Denmark · Cardil
  • Estonia · Diltiazem Lannacher
  • Spain · Angiodrox, Carreldon Retard
  • Finland · Dilzem
  • France · Bi Tildiem L.P., Chlorhydrate De Diltiazem Viatris
  • United Kingdom (Northern Ireland) · Adizem-Sr, Adizem-Xl
  • Greece · Dipen, Elvesil
  • Croatia · Aldizem
  • Hungary · Blocalcin
  • Ireland · Adizem-Sr, Adizem-Xl
  • Iceland · Cardil
  • Italy · Altiazem, Diladel
  • Lithuania · Diltiazem Lannacher
  • Luxembourg · Diltiazem Retard Eg, Progor
  • Latvia · Diltiazem Lannacher
  • Malta · Denazox, Diazem
  • Netherlands · Diltiazem Aurobindo, Diltiazem Hcl Retard Mylan
  • Poland · Dilzem Retard
  • Portugal · Anatop, Anotrit
  • Romania · Diltiazem Arena, Diltiazem Eipico
  • Slovenia · Aldizem
  • Slovakia · Diacordin Retard

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c2cc634e-825e-40a1-a069-27f11037c21a
GET /v1/drugs/c2cc634e-825e-40a1-a069-27f11037c21a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "240",
  "substance": "DILTIAZEM HYDROCHLORIDE",
  "productndc": "24979-028",
  "dosage_form": "CAPSULE, EXTENDED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA205231",
  "marketing_category": "ANDA"
}

See everything about diltiazem.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.